Frederico completed his undergraduate training in Portugal, in Biochemistry and then later in Medicine, with a Masters thesis Mindfulness-based Cognitive Therapy. He trained in Psychiatry in Oxford and is currently a Consultant Child and Adolescent Psychiatrist in the NHS.
During his psychiatry training Frederico collaborated with Kosmicare in Portugal, and later joined the Imperial College Centre for Psychedelic Research where he is an Honorary Research Fellow and has worked as a psychiatrist and guide on clinical studies of psilocybin for depression and anorexia, supervised by Tim Read. Alongside his clinical work he collaborates on developing psychologically-informed approaches in the UK’s first NHS Ketamine Clinic at Oxford Health Foundation Trust.
He is a member of the Royal College of Psychiatry Working Group for Psychedelics within the Faculty of Psychotherapy, developing a guidance document for psychedelic-assisted therapy.
In Portugal, Frederico is a collaborator with Safe Journey and part of the Eleuzis project, working with the Portuguese parliament to advocate for legislative change for psychedelic therapies.
Frederico’s main interests lie in the practice and understanding of the therapeutic processes inherent to psychedelic assisted therapies, and the development of coherent, equitative and safe models for expanded access to these treatments, within and without healthcare settings. He is interested in societal and community-based approaches to problems of mental health and wellbeing, especially in children and young people.